<div id="readability-page-1"><div><p>Kaneka Corporation has begun sales of its i-ED COIL, a brain aneurysm embolization coil in Europe as of October. The product obtained EC certification under an EU Medical Device Regulation in July and will be distributed primarily in Europe through Kaneka Medical Europe N.V. The i-ED COIL provides world-class flexibility, enabled by its specialized wire thickness and structural features. This flexibility enables coils to be packed more densely within aneurysms than conventional products and allows treatment of aneurysms with irregular shapes.</p><p>Its role in reducing the risk of aneurysm rupture is highly regarded by physicians, and since its launch in the Japanese market in 2019, sales have continued to grow steadily. Kaneka is expanding its business in a wide range of fields, which include devices for the treatment of cardiac, peripheral vascular, and cerebrovascular diseases, as well as medical devices used in the treatment of gastrointestinal tract diseases. Looking ahead, company aim to strengthen the global reach of products such as i-ED COIL and achieve sales of JPY 300 billion by 2030 in the Health Care Solution Unit including these medical businesses.</p></div></div>

4118

<p>金華株式會社已於 10 月在歐洲推出其 i-ED COIL 腦動脈瘤栓塞線圈，此前於 7 月獲得了歐洲認證。該產品在治療不規則形狀的動脈瘤時提供了更好的靈活性，並預計能降低破裂風險。自 2019 年在日本推出以來，銷售穩步增長。金華計劃擴大其醫療器械業務，並在 2030 年前實現健康護理解決方案部門 3000 億日元的銷售目標</p>

金化公司通過在歐洲推出 i-ED COIL 擴大其全球影響力